SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Pocock NA, Eisman JA, Hopper JL, Yeates MG, Sambrook PN, Eberi S 1987 Genetic deteminants of bone mass in adults. A twin study. J Clin Invest 80:706710.
  • 2
    Langdahl BL, Knudsen JY, Jensen HK, Gregersen N, Eriksen EF 1997 A sequence variation: 713–8delC in the transforming growth factor-b1 gene has higher prevalence in osteoporotic women than in normal women and is associated with very low bone mass in osteoporotic women and increased bone turnover in both osteoporotic and normal women. Bone 20:289294.
  • 3
    Grant SFA, Reid DM, Blake G, Herd R, Fogelman I, Ralston SH 1996 Reduced bone density and osteoporosis associated with a polymorphic Sp1 binding site in the collagen type I a 1 gene. Nat Genet 14:203205.
  • 4
    Morrison NA, Qi JC, Tokita A, Kelly PJ, Crofts L, Nguyen TV, Sambrook PN, Eisman JA 1994 Prediction of bone density from vitamin D receptor alleles. Nature 367:284287.
  • 5
    Murray RE, McGuigan F, Grant SFA, Reid DM, Ralston SH 1997 Polymorphisms of the interleukin-6 gene are associated with bone mineral density. Bone 21:8992.
  • 6
    Keen RW, Woodford-Richens KL, Lanchbury JS, Spector TD 1998 Allelic variation at the interleukin-1 receptor antagonist gene is associated with early postmenopausal bone loss at the spine. Bone 23:367371.
  • 7
    Langdahl BL, Løkke E, Carstens M, Stenkjær LL, Eriksen EF 1999 A 86 base pair repeat polymorphism in the interleukin 1 receptor antagonist gene is associated with osteoporotic fractures, sequence variations in the coding regions and a polymorphism in the promoter of the interleukin 1b gene are not. J Bone Miner Res 15:402414.
  • 8
    Masi L, Becherini L, Gennari L, Colli E, Cepollaro C, Gonnelli S, Brandi ML 1997 Allelic variants of human calcitonin receptor in Italian women. J Bone Miner Res 12(Suppl 1):257.
  • 9
    Smith EP, Boyd J, Frank GR, Takahashi H, Cohen RM, Specker B, Williams TC, Lubahn DB, Korach KS 1994 Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man. N Engl J Med 331:10561061.
  • 10
    Morishima A, Grumbach MM, Simpson ER, Fisher C, Qin K 1995 Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens. J Clin Endocrinol Metab 80:36893698.
  • 11
    Khosla S, Melton III LJ, Atkinson EJ, O'Fallon WM, Klee GG, Riggs BL 1998 Relationship of serum sex steroid levels and bone turnover markers with bone mineral density in men and women: A key role for bioavailable estrogen. J Clin Endocrinol Metab 83:22662274.
  • 12
    Cummings SR, Browner WS, Bauer D, Stone K, Ensrud K, Jamal S, Ettinger B 1998 Endogenous hormones and the risk of hip and vertebral fractures among older women. N Engl J Med 339:733738.
  • 13
    Ettinger B, Pressman A, Sklarin P, Bauer DC, Cauley JA, Cummings SR 1998 Associations between low levels of serum estradiol, bone density, and fractures among elderly women: The study of osteoporotic fractures. J Clin Endocrinol Metab 83:22392243.
  • 14
    Stone K, Bauer DC, Black DM, Sklarin P, Ensrud KE, Cummings SR 1998 Hormonal predictors of bone loss in the elderly women: A prospective study. J Bone Miner Res 13:11671174.
  • 15
    Eriksen EF, Colvard DS, Berg NJ, Graham ML, Mann KG, Spelsberg TC, Riggs BL 1988 Evidence of estrogen receptors in normal human osteoblast-like cells. Science 241:8486.
  • 16
    Hoyland JA, Mee AP, Baird P, Braidman IP, Mawer EB, Freemont AJ 1997 Demonstration of estrogen receptor mRNA in bone using in situ reverse-transcriptase polymerase chain reaction. Bone 20:8792.
  • 17
    Shevde NK, Pike JW 1996 Estrogen modulates the recruitment of myelopoitic cell progenitors in rat through a stromal cell-independent mechanism involving apoptosis. Blood 87:26832692.
  • 18
    Mano H, Yuasa T, Kameda T, Miyazawa K, Nakamaru Y, Shiokawa M, Mori Y, Yamada T, Miyata K, Shindo H, Azuma H, Hakeda Y, Kumegawa M 1996 Mammalian mature osteoclasts as estrogen target cells. Biochem Biophys Res Commun 223:637642.
  • 19
    Ponglikitmongkol M, Green S, Chambon P 1988 Genomic organization of the human oestrogen receptor gene. EMBO J 7:33853388.
  • 20
    Enmark E, Pelto-Huikko M, Grandien K, Lagercrantz S, Lagercrantz J, Fried G, Nordenskjöld M, Gustafsson J-Å 1997 Human estrogen receptor b-gene structure, chromosomal localization and expression pattern. J Clin Endocrinol Metab 82:42584265.
  • 21
    del-Senno L, Aguiari GL, Piva R 1992 Dinucleotide repeat polymorphism in the human estrogen receptor (ESR) gene. Hum Mol Genet 1:354.
  • 22
    Syrrou M, Georgiou I, Patsalis PC, Bouba I, Adonakis G, Pagoulatos GN 1999 Fragile X premutations and (TA)n estrogen receptor polymorphism in women with ovarian dysfunction. Am J Med Genet 28:306308.
  • 23
    Sano M, Inoue S, Hosoi T, Ouchi Y, Emi M, Shiraki M, Orimo H 1995 Association of estrogen receptor dinucleotide repeat polymorphism with osteoporosis. Biochem Biophys Res Commun 217:378383.
  • 24
    Taylor JA, Li Y, You M, Wilcox AJ, Liu E 1992 B region variant of the estrogen receptor gene. Nucleic Acids Res 20:2895.
  • 25
    Garcia T, Lehrer S, Bloomer WD, Schachter BS 1988 A variant estrogen receptor messenger ribonucleic acid is associated with reduced levels of estrogen binding in human mammary tumors. Mol Endocrinol 2:785791.
  • 26
    Lehrer S, Sanchez M, Song HK, Dalton J, Levine E, Savoretti P, Thung SN, Schachter BS 1990 Oestrogen receptor B-region polymorphism and spontaneous abortion in women with breast cancer. Lancet 335:622624.
  • 27
    Lehrer SP, Schmutzler RK, Rabin JM, Schachter BS 1993 An estrogen receptor genetic polymorphism and a history of spontaneous abortion—correlation in women with estrogen receptor positive breast cancer but not in women with estrogen receptor negative breast cancer or in women without cancer. Breast Cancer Res Treat 26:175180.
  • 28
    Berkowitz GS, Stone JL, Lehrer SP, Marcus M, Lapinski RH, Schachter BS 1994 An estrogen receptor genetic polymorphism and the risk of primary and secondary recurrent spontaneous abortion. Am J Obstet Gynecol 171:15791584.
  • 29
    Taylor JA, Wilcox AJ, Bowes WA, Li Y, Liu ET, You M 1993 Risk of miscarriage and a common variant of the estrogen receptor gene. Am J Epidemiol 137:13611364.
  • 30
    Schmutzler RK, Sanchez M, Lehrer S, Chaparro CA, Phillips C, Rabin J, Schachter B 1991 Incidence of an estrogen receptor polymorphism in breast cancer patients. Breast Cancer Res Treat 19:111117.
  • 31
    Castagnoli A, Maestri I, Bernardi F, DelSenno L 1987 PvuII RFLP inside the human estrogen receptor gene. Nucleic Acids Res 15:866.
  • 32
    Oi JC, Morrison NA, Nguyen TV, White CP, Kelly PJ, Sambrook PN, Eisman JA 1995 Estrogen receptor genotypes and bone mineral density in women and men. J Bone Miner Res 10(Suppl 1):S170.
  • 33
    Kobayashi S, Inoue S, Hosoi T, Ouchi Y, Shiraki M, Orimo H 1996 Association of bone mineral density with polymorphism of the estrogen receptor gene. J Bone Miner Res 11:306311.
  • 34
    Willing M, Sowers M, Aron D, Clark MK, Burns T, Bunten C, Crutchfield M, D'Agostino D, Jannausch M 1998 Bone mineral density and its change in white women: Estrogen and vitamin D receptor genotypes and their interaction. J Bone Miner Res 13:695705.
  • 35
    Mizunuma H, Hosoi T, Okano H, Soda M, Tokizawa T, Kagami I, Miyamoto S, Ibuki Y, Inoue S, Shiraki M, Ouchi Y 1997 Estrogen receptor gene polymorphism and bone mineral density at the lumbar spine of pre- and postmenopausal women. Bone 21:379383.
  • 36
    Ongphiphadhanakul B, Rajatanavin R, Chanprasertyothin S, Piaseu N, Chailurkit L, Sirisriro R, Komindr S 1998 Estrogen receptor gene polymorphism is associated with bone mineral density in premenopausal women but not in postmenopausal women. J Endocrinol Invest 21:487493.
  • 37
    Ongphiphadhanakul B, Rajatanavin R, Chanpresertyothin S, Piaseu N, Chailurkit L 1998 Serum oestradiol and estrogen-receptor gene polymorphism are associated with bone mineral density independently of serum testosterone in normal males. Clin Endocrinol (Oxf) 49:803809.
  • 38
    Deng HW, Li J, Li J-L, Johnson M, Gong G, Davis M, Recker RR 1998 Change of bone mass in postmenopausal caucasian women with and without hormone replacement therapy is associated with vitamin D receptor and estrogen receptor genotypes. Hum Genet 103:576585.
  • 39
    Keen RW, Woodford-Richens KL, Lanchbury JS, Spector TD 1996 Peak bone mass, early postmenopausal bone loss and polymorphism at the estrogen receptor gene. Osteoporos Int 6(Suppl 1):102.
  • 40
    Kurabayashi T, Tomita M, Matsushita H, Yahata T, Honda A, Takakuwa K, Tanaka K 1999 Association of vitamin D and estrogen receptor gene polymorphism with the effect of hormone replacement therapy on bone mineral density in Japanese women. Am J Obstet Gynecol 180:11151120.
  • 41
    Han KO, Moon IG, Kang YS, Chung HY, Min HK, Han IK 1997 Nonassociation of estrogen receptor genotypes with bone mineral density and estrogen responsiveness to hormone replacement therapy in Korean postmenopausal women. J Clin Endocrinol Metab 82:991995.
  • 42
    Gennari L, Becherini L, Masi L, Mansani T, Gonnelli S, Cepollaro C, Martini S, Montagnani A, Lentini G, Becorpi AM, Brandi ML 1998 Vitamin D and estrogen receptor allelic variants in Italian postmenopausal women: Evidence of multiple gene contribution to bone mineral density. J Clin Endocrinol Metab 83:939944.
  • 43
    Genant HK, Grampp S, Glüer CC, Faulkner KG, Jergas M, Engelke K, Hagiwara S, vanKuijk C 1994 Universal standardization for dual x-ray absorptiometry: Patient and phantom cross-calibration results. J Bone Miner Res 9:15031514.
  • 44
    Risteli J, Niemi S, Elomaa T, Risteli L 1991 Bone resorption assay based on a peptide liberated during type I collagen degradation. J Bone Miner Res 6:S251.
  • 45
    Nielsen HK, Laurberg P, Brixen K, Mosekilde L 1991 Relation between the diurnal variation in serum osteocalcin, and the variation in serum concentrations of cortisol, PTH(1-84) and ionized calcium in normal individuals. Acta Endocrinol 124:391398.
  • 46
    Andersen TI, Heimdal KR, Skrede M, Tveit K, Berg K, Børresen A-L 1994 Oestrogen receptor (ESR) polymorphims and breast cancer susceptibility. Hum Genet 94:665670.
  • 47
    Yaich L, Dupont WD, Cavener DR, Parl FF 1992 Analysis of the PvuII restriction fragment-length polymorphism and exon structure of the estrogen receptor gene in breast cancer and peripheral blood. Cancer Res 52:7783.
  • 48
    Piva R, DelSenno L 1993 Analysis of a DNA sequence upstream of the human estrogen receptor gene. Ann NY Acad Sci 684:235238.
  • 49
    Vega EM, Egea MA, Mautalen CA 1994 Influence of the menopausal age on the severity of osteoporosis in women with vertebral fractures. Maturitas 19:117124.
  • 50
    Vandevyver C, Vanhoof J, Declerck K, Stinissen P, Vandervorst C, Michiels L, Cassiman JJ, Boonen S, Raus J, Geusens P 1999 Lack of association between estrogen receptor genotypes and bone mineral density, fracture history, or muscle strength in elderly women. J Bone Miner Res 14:15761582.
  • 51
    Gasch A, Hinz U, Renkawitz-Pohl R 1989 Intron and upstream sequences regulate expression of the Drosophila beta 3-tubulin gene in the visceral and somatic musculature, respectively. Proc Natl Acad Sci USA 86:32153218.
  • 52
    Aronow B, Lattier D, Silbiger R, Dusing M, Hutton J, Jones G, Stock J, McNeish J, Potter S, Witte D 1989 Evidence for a complex regularoty array in the first intron of human adenosine deaminase gene. Genes Dev 3:13841400.
  • 53
    Laurie CC, Stam LF 1994 The effect of an intronic polymorphism on alcohol dehydrogenase expression in Drosophila melanogaster. Genetics 138:379385.
  • 54
    Heimdal K, Andersen TI, Skrede M, Fosså SD, Berg K, Børresen A-L 1995 Association studies of estrogen receptor polymorphisms in a norwegian testicular cancer population. Cancer Epidemiol Biomarkers Prev 4:123126.
  • 55
    Matsubara Y, Murata M, Kawano K, Zama T, Aoki N, Yoshino H, Watanabe G, Ishikawa K, Ikeda Y 1997 Genotype distribution of estrogen receptor polymorphisms in men and postmenopausal women from healthy and coronary populations and its relation to serum lipid levels. Arterioscler Thromb Vasc Biol 17:30063012.